PPT-Antimicrobial resistance (AMR) –

a pharmaceutical industry perspective 17 th November 2018 Dr Bryan Deane Dept of Research Medical amp Innovation Introduction the ABPI the biopharmaceutical industry AMR the issue. Easow Chiranjoy Mukhopadhyay PG Shivananda Department of Microbiology Manipal College of Medical Sciences Pokhara Nepal Received January 13 2005 Background objectives Shigellae play an important role as a causative organism of acute gastroenterit (AMR) profiling . in . Escherichia coli. from farmed and wild animals in the Mekong delta of Vietnam. Nguyen . Thi. . Nhung. Oxford University Clinical Research Unit, HCMC, Vietnam. Biodiversity and Health Symposium. Dr. Rachel Levine. Pennsylvania Physician General . Antimicrobial Resistance (AMR). Antimicrobial resistance (AMR) is the change in microbes (e.g. bacteria, parasites and fungi) which enable them to withstand treatment by antimicrobial drugs, meaning that the drugs no longer work, or work less effectively. . Dr Andrea Ammon, ECDC Director, . 27 June 2017, European Parliament. 0. 200. 400. 600. 800. 1000. 1900. 1920. 1940. 1960. 1980. 2000. 1918. Influenza pandemic. 1924. Plague: last human-to-human transmission. (2011 – 2020). &. Global action plan on AMR . (2015). Dr Danilo Lo Fo . Wong. Programme Manager AMR. WHO Regional Office for Europe. WHO efforts on antimicrobial resistance. 2014. 2015. 2001. 2003. Insert your organisation’s name here . Insert presenter’s name here . #. worldantimicrobialawarenessweek. Overview. Antibiotics are . vital life-saving . medicines . Antimicrobial resistance is both a global and local problem. Therapy. The development of antimicrobial drugs represents one of the most important advances in therapeutics, both in the control or cure of serious infections and in the prevention and treatment of infectious complications of other therapeutic modalities such as cancer chemotherapy, immunosuppression, and surgery.. Robinson TRUONG. 1,2. , Vincent TANG. 1. , Troy GRENNAN. 3. & Darrell H.S. TAN. 1, 2, 4, . 5. 1.. . Faculty . of Medicine, University of . Toronto,. . 2.. . Centre . for Urban Health Solutions, St. Michael’s . Antibiotic Use in the VFD & MRSA Era. Dr Justin Bergeron. Maine Assistant State Veterinarian. DEPARTMENT OF AGRICULTURE, CONSERVATION & FORESTRY. DIVISION . OF ANIMAL AND PLANT HEALTH. Who Is This Guy. Consequences of AMR. What can we do ?. Microbiology and the antibiotic apocalypse. Dr Dave Whitworth. dew@aber.ac.uk. Reader in Biochemistry. Microbiology and the antibiotic apocalypse. What are antibiotics ?. Where did you getHEALTH FACILITY O R HEALTH FACILITY O R HEALTH FACILITY O R (NAME OF MEDICINE)? A MOBILE OUTREACH R 02WORKE R 02WORKE R .................................02PHARMACY / PHARMACY / PHARM RESISTANCE Interagency Task Force on Antimicrobial Resistance Co - Chairs: Centers for Disease Control and Prevention Food and Drug Administration National Institutes of Health Participating Agencie s 1. 1. Antibacterial resistance in ophthalmic infections: a multi-centre analysis across UK care settings//BMC Infectious Diseases.- volume 19, Article number: 768 (2019) . Educational MODULE. November 2020. antibiotics and other antimicrobials becoming less effective. infections being increasingly difficult or impossible to treat.. For patients, this results in prolonged illness and sometimes death.. Learn more about AMR, its impact on the.